Skip to main content
Erschienen in: Annals of Surgical Oncology 8/2009

01.08.2009 | Healthcare Policy and Outcomes

Colorectal Cancer Screening Among First-Degree Relatives of Colorectal Cancer Patients: Benefits and Barriers

verfasst von: Lloyd A. Mack, MD, MSc, FRCSC, Linda S. Cook, PhD, Walley J. Temple, MD, FRCSC, FACS, Linda E. Carlson, MD, PhD, Robert J. Hilsden, MD, PhD, FRCPC, Elizabeth Oddone Paolucci, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Individuals with a first-degree family history of colorectal cancer (CRC) are at increased risk of CRC. Study objectives were: (1) to estimate the proportion of first-degree relatives (FDR) of CRC patients being screened for CRC and (2) to identify predictors of screened behavior.

Methods

A questionnaire was mailed to 640 stage I–III CRC patients from a population-based registry to identify FDR. A survey was sent to 747 FDR, aged 40 or older, to assess CRC screening, knowledge, demographics, access, benefits, and barriers of CRC screening. Factor analysis was used to detect underlying constructs. Predictors of screening were explored by multivariate analysis (MVA).

Results

There was a 54% and 51% response for patients and FDR, respectively. Among FDR, 86% were born in Canada, 94% spoke English, 93.5% had a high school education, 73% were married, and 55% were employed. The age distribution was: 40–44 years (19.7%), 45–49 (19.1%), 50–54 (16%), 55–59 (15.2%), 60–64 (9.8%), and >65 (18%). Seventy percent had undergone CRC screening with 60% adherent to current guidelines. Of those screened, 33.7% had fecal occult blood testing, 19.4% had barium enema, 10.7% had sigmoidoscopy, and 58.7% had colonoscopy. Five constructs influencing CRC screening include: salience and coherence, perceived susceptibility, response efficacy, social influence, and cancer worries. MVA determined age >50 years as the most important predictor of screening.

Conclusion

In this survey, 70% of FDR of CRC patients had undergone screening; age was the most important predictor. Understanding underlying constructs influencing screening behavior may improve uptake of CRC screening in this population.
Literatur
1.
Zurück zum Zitat National Cancer Institute of Canada. Canadian Cancer Statistics. Toronto, Ontario; 2001. National Cancer Institute of Canada. Canadian Cancer Statistics. Toronto, Ontario; 2001.
2.
Zurück zum Zitat Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–32.PubMed Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–32.PubMed
3.
Zurück zum Zitat Winawer SJ, Zauber AG, Ho MN, O’Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977–81.PubMedCrossRef Winawer SJ, Zauber AG, Ho MN, O’Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977–81.PubMedCrossRef
4.
Zurück zum Zitat McLeod RS, Canadian task force on preventive health care. Screening strategies for colorectal cancer: a systematic review of the evidence. Can J Gastroenterol. 2001;15:647–60.PubMed McLeod RS, Canadian task force on preventive health care. Screening strategies for colorectal cancer: a systematic review of the evidence. Can J Gastroenterol. 2001;15:647–60.PubMed
5.
Zurück zum Zitat McGregor SE, Hilsden RJ, Murray A, Bryant HE. Colorectal cancer screening: practices and opinions of primary care physicians. Prev Med. 2004;39:279–85.PubMedCrossRef McGregor SE, Hilsden RJ, Murray A, Bryant HE. Colorectal cancer screening: practices and opinions of primary care physicians. Prev Med. 2004;39:279–85.PubMedCrossRef
7.
Zurück zum Zitat Fuchs CS, Giovannucci EL, Colditz GA, Stampfer MJ, Giovannucci EL, Hunter DJ, et al. A prospective study of family history and the risk of colorectal cancer. N Engl J Med. 1994;331:1669–74.PubMedCrossRef Fuchs CS, Giovannucci EL, Colditz GA, Stampfer MJ, Giovannucci EL, Hunter DJ, et al. A prospective study of family history and the risk of colorectal cancer. N Engl J Med. 1994;331:1669–74.PubMedCrossRef
8.
Zurück zum Zitat Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96:2992–3003.PubMedCrossRef Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96:2992–3003.PubMedCrossRef
9.
Zurück zum Zitat U.S. Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002;133:573–84. U.S. Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002;133:573–84.
10.
Zurück zum Zitat Simmang CL, Senatore P, Lowry A, Hicks T, Burnstein M, Dentsman F, et al. Practice parameters for detection of colorectal neoplasms. The Standards Committee, The American Society of Colon and Rectal Surgeons. Dis Colon Rectum. 1999;42:1123–9.PubMedCrossRef Simmang CL, Senatore P, Lowry A, Hicks T, Burnstein M, Dentsman F, et al. Practice parameters for detection of colorectal neoplasms. The Standards Committee, The American Society of Colon and Rectal Surgeons. Dis Colon Rectum. 1999;42:1123–9.PubMedCrossRef
11.
Zurück zum Zitat Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin. 2004;54:41–52.PubMedCrossRef Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin. 2004;54:41–52.PubMedCrossRef
12.
Zurück zum Zitat Mack LA, Stuart H, Temple WJ. Survey of colorectal cancer screening practices in a large Canadian urban centre. Can J Surg. 2004;47:189–94.PubMed Mack LA, Stuart H, Temple WJ. Survey of colorectal cancer screening practices in a large Canadian urban centre. Can J Surg. 2004;47:189–94.PubMed
13.
Zurück zum Zitat McGregor SE, Hilsden RJ, Li FX, Bryant HE, Murray A. Low uptake of colorectal cancer screening 3 yr after release of national recommendations for screening. Am J Gastroenterol. 2007;102:1727–35.PubMedCrossRef McGregor SE, Hilsden RJ, Li FX, Bryant HE, Murray A. Low uptake of colorectal cancer screening 3 yr after release of national recommendations for screening. Am J Gastroenterol. 2007;102:1727–35.PubMedCrossRef
14.
Zurück zum Zitat Rawl S, Champion V, Menon U, Loehrer PJ Sr, Vance GH, Skinner CS. Validation of scales to measure benefits and barriers to colorectal cancer screening. J Psychosoc Oncol. 2001;19:63.CrossRef Rawl S, Champion V, Menon U, Loehrer PJ Sr, Vance GH, Skinner CS. Validation of scales to measure benefits and barriers to colorectal cancer screening. J Psychosoc Oncol. 2001;19:63.CrossRef
15.
Zurück zum Zitat Tiro JA, Vernon SW, Hyslop T, Myers RE. Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening among African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev. 2005;14:2855–61.PubMedCrossRef Tiro JA, Vernon SW, Hyslop T, Myers RE. Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening among African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev. 2005;14:2855–61.PubMedCrossRef
16.
Zurück zum Zitat Dillman DA. Survey implementation. In: Dillman DA editors. Mail and internet surveys: the tailored design method. New York: John Wiley & Sons, Inc.; 2000. p. 149–93. Dillman DA. Survey implementation. In: Dillman DA editors. Mail and internet surveys: the tailored design method. New York: John Wiley & Sons, Inc.; 2000. p. 149–93.
17.
Zurück zum Zitat Kalantar JS, Talley NJ. The effects of lottery incentive and length of questionnaire on health survey response rates: a randomized study. J Clin Epidemiol. 1999;52:1117–22.PubMedCrossRef Kalantar JS, Talley NJ. The effects of lottery incentive and length of questionnaire on health survey response rates: a randomized study. J Clin Epidemiol. 1999;52:1117–22.PubMedCrossRef
18.
Zurück zum Zitat Roberts LM, Wilson S, Roalfe A, Bridge P. A randomised controlled trial to determine the effect on response of including a lottery incentive in health surveys. BMC Health Serv Res. 2004;4:30.PubMedCrossRef Roberts LM, Wilson S, Roalfe A, Bridge P. A randomised controlled trial to determine the effect on response of including a lottery incentive in health surveys. BMC Health Serv Res. 2004;4:30.PubMedCrossRef
19.
Zurück zum Zitat Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol. 1997;50:1129–36.PubMedCrossRef Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol. 1997;50:1129–36.PubMedCrossRef
20.
Zurück zum Zitat Vernon SW, Myers RE, Tilley BC. Development and validation of an instrument to measure factors related to colorectal cancer screening adherence. Cancer Epidemiol Biomarkers Prev. 1997;6:825–32.PubMed Vernon SW, Myers RE, Tilley BC. Development and validation of an instrument to measure factors related to colorectal cancer screening adherence. Cancer Epidemiol Biomarkers Prev. 1997;6:825–32.PubMed
21.
Zurück zum Zitat Codori AM, Petersen GM, Miglioretti DL, Boyd P. Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention. Prev Med. 2001;33:128–36.PubMed Codori AM, Petersen GM, Miglioretti DL, Boyd P. Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention. Prev Med. 2001;33:128–36.PubMed
22.
Zurück zum Zitat Coronado GD, Farias A, Thompson B, Godina R, Oderkirk W. Attitudes and beliefs about colorectal cancer among Mexican Americans in communities among the US-Mexican border. Ethn Dis. 2006;16:421–7.PubMed Coronado GD, Farias A, Thompson B, Godina R, Oderkirk W. Attitudes and beliefs about colorectal cancer among Mexican Americans in communities among the US-Mexican border. Ethn Dis. 2006;16:421–7.PubMed
23.
Zurück zum Zitat Ramji F, Cotterchio M, Manno M, Rabeneck L, Gallinger S. Association between subject factors and colorectal cancer screening participation in Ontario, Canada. Cancer Detect Prev. 2005;29:221–6.PubMedCrossRef Ramji F, Cotterchio M, Manno M, Rabeneck L, Gallinger S. Association between subject factors and colorectal cancer screening participation in Ontario, Canada. Cancer Detect Prev. 2005;29:221–6.PubMedCrossRef
24.
Zurück zum Zitat Center for Disease Control. Trends in screening for colorectal cancer—United States 1997 and 1999. MMWR CDC. 2001;50:162–6. Center for Disease Control. Trends in screening for colorectal cancer—United States 1997 and 1999. MMWR CDC. 2001;50:162–6.
25.
Zurück zum Zitat Etzioni DA, Ponce NA, Babey SH, Spencer BA, Brown ER, Ko CY, et al. A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey. Cancer. 2004;101:2523–32.PubMedCrossRef Etzioni DA, Ponce NA, Babey SH, Spencer BA, Brown ER, Ko CY, et al. A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey. Cancer. 2004;101:2523–32.PubMedCrossRef
26.
Zurück zum Zitat Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol. 2003;89:2082–91.CrossRef Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol. 2003;89:2082–91.CrossRef
27.
Zurück zum Zitat Cotterchio M, McKeown-Eyssen G, Sutherland H, Buchan G, Aronson M, Easson AM, et al. Ontario Familial Colon Cancer Registry: methods and first-year response rates. Chron Dis Can. 2000;21:81–6. Cotterchio M, McKeown-Eyssen G, Sutherland H, Buchan G, Aronson M, Easson AM, et al. Ontario Familial Colon Cancer Registry: methods and first-year response rates. Chron Dis Can. 2000;21:81–6.
28.
Zurück zum Zitat Madlensky L, Esplen MJ, Gallinger S, McLaughlin JR, Goel V. Relatives of colorectal cancer patients: factors associated with screening behavior. Am J Prev Med. 2003;25:187–94.PubMedCrossRef Madlensky L, Esplen MJ, Gallinger S, McLaughlin JR, Goel V. Relatives of colorectal cancer patients: factors associated with screening behavior. Am J Prev Med. 2003;25:187–94.PubMedCrossRef
29.
Zurück zum Zitat Manne S, Markowitz A, Winawer S, Meropol NJ, Haller D, Rakowski W, et al. Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychol. 2002;21:3–15.PubMedCrossRef Manne S, Markowitz A, Winawer S, Meropol NJ, Haller D, Rakowski W, et al. Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychol. 2002;21:3–15.PubMedCrossRef
30.
Zurück zum Zitat Gordon NP, Hiatt RA, Lampert DI. Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst. 1993;85:566–70.PubMedCrossRef Gordon NP, Hiatt RA, Lampert DI. Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst. 1993;85:566–70.PubMedCrossRef
31.
Zurück zum Zitat Baier M, Calonge N, Cutter G, McClatchey M. Schoentgen S, Hines S, et al. Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomarkers Prev. 2000;9:229–32.PubMed Baier M, Calonge N, Cutter G, McClatchey M. Schoentgen S, Hines S, et al. Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomarkers Prev. 2000;9:229–32.PubMed
32.
Zurück zum Zitat Hawley ST, Levin B, Vernon SW. Colorectal cancer screening by primary care physicians in two medical care organizations. Cancer Detect Prev. 2001;25:309–18.PubMed Hawley ST, Levin B, Vernon SW. Colorectal cancer screening by primary care physicians in two medical care organizations. Cancer Detect Prev. 2001;25:309–18.PubMed
33.
Zurück zum Zitat Read TE, Kodner IJ. Colorectal cancer: risk factors and recommendations for early detection. Am Fam Physician. 1999;59:3083–92.PubMed Read TE, Kodner IJ. Colorectal cancer: risk factors and recommendations for early detection. Am Fam Physician. 1999;59:3083–92.PubMed
34.
Zurück zum Zitat Guidelines & Protocols Advisory Committee. Detection of colorectal neoplasms in asymptomatic patients. British Columbia, BC Health Services; 2004. Guidelines & Protocols Advisory Committee. Detection of colorectal neoplasms in asymptomatic patients. British Columbia, BC Health Services; 2004.
35.
Zurück zum Zitat Maiman LA, Becker MH. The health belief model: origins and correlates in psychological theory. Health Educ Monogr. 1974;2:9–26. Maiman LA, Becker MH. The health belief model: origins and correlates in psychological theory. Health Educ Monogr. 1974;2:9–26.
36.
Zurück zum Zitat Rawl SM, Menon U, Champion VL, Foster JL, Skinner CS. Colorectal cancer screening beliefs: focus groups with first-degree relatives. Cancer Pract. 2000;8:32–7.PubMedCrossRef Rawl SM, Menon U, Champion VL, Foster JL, Skinner CS. Colorectal cancer screening beliefs: focus groups with first-degree relatives. Cancer Pract. 2000;8:32–7.PubMedCrossRef
37.
Zurück zum Zitat Madlensky L, Esplen MJ, Goel V. Reasons given by relatives of colorectal cancer patients for not undergoing screening. Prev Med. 2004;39:643–8.PubMedCrossRef Madlensky L, Esplen MJ, Goel V. Reasons given by relatives of colorectal cancer patients for not undergoing screening. Prev Med. 2004;39:643–8.PubMedCrossRef
38.
Zurück zum Zitat Montgomery GH, Erblich J, Dilorenzo T, Bovbjerg DH. Family and friends with disease: their impact on perceived risk. Prev Med. 2003;37:242–9.PubMedCrossRef Montgomery GH, Erblich J, Dilorenzo T, Bovbjerg DH. Family and friends with disease: their impact on perceived risk. Prev Med. 2003;37:242–9.PubMedCrossRef
39.
Zurück zum Zitat Blalock SJ, Devellis B, Afifi RA, Sandler RS. Risk perceptions and participation in colorectal cancer screening. Health Psychol. 1990;9:792–806.PubMedCrossRef Blalock SJ, Devellis B, Afifi RA, Sandler RS. Risk perceptions and participation in colorectal cancer screening. Health Psychol. 1990;9:792–806.PubMedCrossRef
40.
Zurück zum Zitat Stermer T, Hodgson S, Kavalier F, Watts S, Jones R. Patients’ and professionals’ opinions of services for people at an increased risk of colorectal cancer: an exploratory qualitative study. Fam Cancer. 2004;3:49–53.PubMedCrossRef Stermer T, Hodgson S, Kavalier F, Watts S, Jones R. Patients’ and professionals’ opinions of services for people at an increased risk of colorectal cancer: an exploratory qualitative study. Fam Cancer. 2004;3:49–53.PubMedCrossRef
41.
Zurück zum Zitat Glanz K, Steffen AD, Taglialatela LA. Effects of colon cancer risk counseling for first-degree relatives. Cancer Epidemiol Biomarkers Prev. 2007;16:1485–91.PubMedCrossRef Glanz K, Steffen AD, Taglialatela LA. Effects of colon cancer risk counseling for first-degree relatives. Cancer Epidemiol Biomarkers Prev. 2007;16:1485–91.PubMedCrossRef
42.
Zurück zum Zitat Alberta Cancer Board Cancer Screening Programs. Alberta colorectal cancer screening Program. Alberta, Alberta Cancer Board; 2008. Alberta Cancer Board Cancer Screening Programs. Alberta colorectal cancer screening Program. Alberta, Alberta Cancer Board; 2008.
43.
Zurück zum Zitat Taylor ML, Anderson R. Colorectal cancer screening: physician attitudes and practices. WMJ. 2002;101:39–43.PubMed Taylor ML, Anderson R. Colorectal cancer screening: physician attitudes and practices. WMJ. 2002;101:39–43.PubMed
44.
Zurück zum Zitat Mitchell RJ, Brewster D, Campbell H, Porteous ME, Wyllie AH, Bird CC, et al. Accuracy of reporting of family history of colorectal cancer. Gut. 2004;53:291–5.PubMedCrossRef Mitchell RJ, Brewster D, Campbell H, Porteous ME, Wyllie AH, Bird CC, et al. Accuracy of reporting of family history of colorectal cancer. Gut. 2004;53:291–5.PubMedCrossRef
45.
Zurück zum Zitat Lynch KL, Ahnen DJ, Byers T, Weiss DG, Lieberman DA. First-degree relatives of patients with advanced colorectal adenomas have an increased prevalence of colorectal cancer. Clin Gastroenterol Hepatol. 2003;1:96–102.PubMedCrossRef Lynch KL, Ahnen DJ, Byers T, Weiss DG, Lieberman DA. First-degree relatives of patients with advanced colorectal adenomas have an increased prevalence of colorectal cancer. Clin Gastroenterol Hepatol. 2003;1:96–102.PubMedCrossRef
46.
Zurück zum Zitat St. John DJB, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ES. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med. 1993;118:785–90.PubMed St. John DJB, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ES. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med. 1993;118:785–90.PubMed
Metadaten
Titel
Colorectal Cancer Screening Among First-Degree Relatives of Colorectal Cancer Patients: Benefits and Barriers
verfasst von
Lloyd A. Mack, MD, MSc, FRCSC
Linda S. Cook, PhD
Walley J. Temple, MD, FRCSC, FACS
Linda E. Carlson, MD, PhD
Robert J. Hilsden, MD, PhD, FRCPC
Elizabeth Oddone Paolucci, PhD
Publikationsdatum
01.08.2009
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 8/2009
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-009-0528-z

Weitere Artikel der Ausgabe 8/2009

Annals of Surgical Oncology 8/2009 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.